These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

443 related items for PubMed ID: 16957578

  • 1. Correlation among pathology, genotype, and patient outcomes in glioblastoma.
    Homma T, Fukushima T, Vaccarella S, Yonekawa Y, Di Patre PL, Franceschi S, Ohgaki H.
    J Neuropathol Exp Neurol; 2006 Sep; 65(9):846-54. PubMed ID: 16957578
    [Abstract] [Full Text] [Related]

  • 2. Genetic analyses for predictors of radiation response in glioblastoma.
    Shih HA, Betensky RA, Dorfman MV, Louis DN, Loeffler JS, Batchelor TT.
    Int J Radiat Oncol Biol Phys; 2005 Nov 01; 63(3):704-10. PubMed ID: 15978739
    [Abstract] [Full Text] [Related]

  • 3. Amplification of the epidermal growth factor receptor gene in glioblastoma: an analysis of the relationship between genotype and phenotype by CISH method.
    Miyanaga T, Hirato J, Nakazato Y.
    Neuropathology; 2008 Apr 01; 28(2):116-26. PubMed ID: 18021194
    [Abstract] [Full Text] [Related]

  • 4. Prognostic stratification of patients with anaplastic gliomas according to genetic profile.
    Dehais C, Laigle-Donadey F, Marie Y, Kujas M, Lejeune J, Benouaich-Amiel A, Pedretti M, Polivka M, Xuan KH, Thillet J, Delattre JY, Sanson M.
    Cancer; 2006 Oct 15; 107(8):1891-7. PubMed ID: 16986124
    [Abstract] [Full Text] [Related]

  • 5. The infrequent simultaneous genetic alterations in glioblastoma multiforme (LOH 10, 17, 19q, TP53 mutation and EGFR amplification) with short clinical course.
    Jesionek-Kupnicka D, Kulczycka D, Rieske P, Szybka M, Jabłońska J, Potemski P, Kolasa P, Liberski PP, Kordek R.
    Pol J Pathol; 2007 Oct 15; 58(2):79-85. PubMed ID: 17715673
    [Abstract] [Full Text] [Related]

  • 6. Genetic pathways to glioblastoma: a population-based study.
    Ohgaki H, Dessen P, Jourde B, Horstmann S, Nishikawa T, Di Patre PL, Burkhard C, Schüler D, Probst-Hensch NM, Maiorka PC, Baeza N, Pisani P, Yonekawa Y, Yasargil MG, Lütolf UM, Kleihues P.
    Cancer Res; 2004 Oct 01; 64(19):6892-9. PubMed ID: 15466178
    [Abstract] [Full Text] [Related]

  • 7. Molecular genetic alterations in glioblastomas with oligodendroglial component.
    Kraus JA, Lamszus K, Glesmann N, Beck M, Wolter M, Sabel M, Krex D, Klockgether T, Reifenberger G, Schlegel U.
    Acta Neuropathol; 2001 Apr 01; 101(4):311-20. PubMed ID: 11355302
    [Abstract] [Full Text] [Related]

  • 8. Methylation of O6-methylguanine DNA methyltransferase and loss of heterozygosity on 19q and/or 17p are overlapping features of secondary glioblastomas with prolonged survival.
    Eoli M, Menghi F, Bruzzone MG, De Simone T, Valletta L, Pollo B, Bissola L, Silvani A, Bianchessi D, D'Incerti L, Filippini G, Broggi G, Boiardi A, Finocchiaro G.
    Clin Cancer Res; 2007 May 01; 13(9):2606-13. PubMed ID: 17473190
    [Abstract] [Full Text] [Related]

  • 9. Population-based study on incidence, survival rates, and genetic alterations of low-grade diffuse astrocytomas and oligodendrogliomas.
    Okamoto Y, Di Patre PL, Burkhard C, Horstmann S, Jourde B, Fahey M, Schüler D, Probst-Hensch NM, Yasargil MG, Yonekawa Y, Lütolf UM, Kleihues P, Ohgaki H.
    Acta Neuropathol; 2004 Jul 01; 108(1):49-56. PubMed ID: 15118874
    [Abstract] [Full Text] [Related]

  • 10. Molecular genetic analysis of deep-seated glioblastomas.
    Hayashi Y, Yamashita J, Watanabe T.
    Cancer Genet Cytogenet; 2004 Aug 01; 153(1):64-8. PubMed ID: 15325097
    [Abstract] [Full Text] [Related]

  • 11. Molecular pathogenesis of pediatric astrocytic tumors.
    Nakamura M, Shimada K, Ishida E, Higuchi T, Nakase H, Sakaki T, Konishi N.
    Neuro Oncol; 2007 Apr 01; 9(2):113-23. PubMed ID: 17327574
    [Abstract] [Full Text] [Related]

  • 12. Magnetic resonance imaging characteristics predict epidermal growth factor receptor amplification status in glioblastoma.
    Aghi M, Gaviani P, Henson JW, Batchelor TT, Louis DN, Barker FG.
    Clin Cancer Res; 2005 Dec 15; 11(24 Pt 1):8600-5. PubMed ID: 16361543
    [Abstract] [Full Text] [Related]

  • 13. Amplification of genes encoding KIT, PDGFRalpha and VEGFR2 receptor tyrosine kinases is frequent in glioblastoma multiforme.
    Joensuu H, Puputti M, Sihto H, Tynninen O, Nupponen NN.
    J Pathol; 2005 Oct 15; 207(2):224-31. PubMed ID: 16021678
    [Abstract] [Full Text] [Related]

  • 14. Genetic alterations in primary glioblastomas in Japan.
    Fukushima T, Favereaux A, Huang H, Shimizu T, Yonekawa Y, Nakazato Y, Ohagki H.
    J Neuropathol Exp Neurol; 2006 Jan 15; 65(1):12-8. PubMed ID: 16410744
    [Abstract] [Full Text] [Related]

  • 15. Heterozygosity status of 1p and 19q and its correlation with p53 protein expression and EGFR amplification in patients with astrocytic tumors: novel series from India.
    Jha P, Agarwal S, Pathak P, Srivastava A, Suri V, Sharma MC, Chosdol K, Srivastava T, Gupta D, Gupta A, Suri A, Sarkar C.
    Cancer Genet Cytogenet; 2010 Apr 15; 198(2):126-34. PubMed ID: 20362227
    [Abstract] [Full Text] [Related]

  • 16. The prognostic relevance of molecular alterations in glioblastomas for patients age < 50 years.
    Korshunov A, Sycheva R, Golanov A.
    Cancer; 2005 Aug 15; 104(4):825-32. PubMed ID: 15981281
    [Abstract] [Full Text] [Related]

  • 17. Population-based studies on incidence, survival rates, and genetic alterations in astrocytic and oligodendroglial gliomas.
    Ohgaki H, Kleihues P.
    J Neuropathol Exp Neurol; 2005 Jun 15; 64(6):479-89. PubMed ID: 15977639
    [Abstract] [Full Text] [Related]

  • 18. Molecular analysis of chromosome 1, 10 and 19 abnormalities in human oligodendroglial tumors: relationship between frequency of LOH grade, age and gender.
    Gresner SM, Rieske P, Wozniak K, Piaskowski S, Jaskolski DJ, Skowronski W, Golanska E, Sikorska B, Liberski PP.
    Clin Neuropathol; 2006 Jun 15; 25(1):18-24. PubMed ID: 16465770
    [Abstract] [Full Text] [Related]

  • 19. Identification of oligodendroglioma specific chromosomal copy number changes in the glioblastoma MI-4 cell line by array-CGH and FISH analyses.
    Magnani I, Moroni RF, Roversi G, Beghini A, Pfundt R, Schoenmakers EF, Larizza L.
    Cancer Genet Cytogenet; 2005 Sep 15; 161(2):140-5. PubMed ID: 16102584
    [Abstract] [Full Text] [Related]

  • 20. Prognostic significance of molecular markers and extent of resection in primary glioblastoma patients.
    Felsberg J, Rapp M, Loeser S, Fimmers R, Stummer W, Goeppert M, Steiger HJ, Friedensdorf B, Reifenberger G, Sabel MC.
    Clin Cancer Res; 2009 Nov 01; 15(21):6683-93. PubMed ID: 19861461
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.